Clinical Trial Update: Dose-response Study of Arginine Supplementation in Severe Sepsis [EARLY_Phase 1]

View source ↗

Summary

Completed early-phase 1 dose-response study evaluating arginine supplementation in patients with severe sepsis and septic shock. The trial investigated safety a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Sepsis, Septic Shock | EARLY_Phase 1 | Status: COMPLETED